These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11913726)
1. The use of animal models in expression pharmacogenomic analyses. Rothberg BE Pharmacogenomics J; 2001; 1(1):48-58. PubMed ID: 11913726 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacogenomics: the frontiers of genome medicine]. Tanaka T; Tsujimoto G; Sugiyama Y; Hashimoto Y Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):141-8. PubMed ID: 12271509 [TBL] [Abstract][Full Text] [Related]
3. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications. Rioux PP Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics and the drug discovery pipeline: when should it be implemented? Penny MA; McHale D Am J Pharmacogenomics; 2005; 5(1):53-62. PubMed ID: 15727489 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics. Albers LJ; Ozdemir V Curr Med Chem; 2004 Feb; 11(3):297-312. PubMed ID: 14965233 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models. Tanaka T; Oka T; Shimada Y; Umemoto N; Kuroyanagi J; Sakamoto C; Zang L; Wang Z; Nishimura Y J Pharmacol Sci; 2008 May; 107(1):8-14. PubMed ID: 18490853 [TBL] [Abstract][Full Text] [Related]
11. [Transcriptome analysis and pharmacogenomics]. Tanaka T Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):241-6. PubMed ID: 11084921 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic applications in clinical drug development. Dracopoli NC Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S57-60. PubMed ID: 12856151 [TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Singh SS Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic gene clusters as drug action mechanisms]. Tanaka T Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():5P-7P. PubMed ID: 14727507 [TBL] [Abstract][Full Text] [Related]
15. En route to precision medicine through the integration of biological sex into pharmacogenomics. Gaignebet L; Kararigas G Clin Sci (Lond); 2017 Feb; 131(4):329-342. PubMed ID: 28159880 [TBL] [Abstract][Full Text] [Related]
16. Preparing for the revolution--pharmacogenomics and the clinical lab. Mehr IJ Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591 [TBL] [Abstract][Full Text] [Related]
17. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Cecchin E; De Mattia E; Ecca F; Toffoli G Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Rukov JL; Shomron N Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics - therapeutic and ethical issues. Patowary S Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851 [TBL] [Abstract][Full Text] [Related]
20. Personalized pharmacogenomics profiling using whole-genome sequencing. Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]